Brief: Agile Therapeutics Reports Q2 Loss Per Share Of $0.12
Aug 11 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $0.12
* Q2 EARNINGS PER SHARE ESTIMATE $-0.14 -- REFINITIV IBES
DATA
* BELIEVE CO IS ON TRACK TO LAUNCH TWIRLA IN Q4 OF 2020
* SEES Q4 REVENUE IN RANGE OF $1 MILLION TO $2 MILLION
Source text for Eikon: ID:nGNX7CFrxg
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt